Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

X

Skip to content
  • LOGIN
  • JOIN
Xtalks
  • Webinars
  • Industries
    • All Life Sciences
    • Pharma
    • Biotech
    • Medtech
    • Healthcare
    • Research
    • Food
  • News & Features
    • All Xtalks Editorial
    • News
    • Blogs
    • Videos
    • Quizzes & Polls
    • Pharmaville
    • Xtalks Spotlight
    • Life Science Podcast
    • Xtalks Clinical Edge™
    • Community Features
    • Peer Circles
  • Industry Jobs
    • Search Jobs
    • Post Job
    • Talent Acquisition & Branding Bundle
  • Partner With Us
    • All Services
    • Host a Webinar
    • Spotlight Videos
    • Editorial Features
    • Xtalks Clinical Edge™ Magazine
    • Life Science Podcast
    • Email Marketing
    • Pharmaville
    • Marketing Insights Blog
  • About
    • About Us
    • Frequently Asked Questions
    • Xtalks Team
    • Join The Community
  • Contact
  • Webinars
  • Industries
    • All Life Sciences
    • Pharma
    • Biotech
    • Medtech
    • Healthcare
    • Research
    • Food
  • News & Features
    • All Xtalks Editorial
    • News
    • Blogs
    • Videos
    • Quizzes & Polls
    • Pharmaville
    • Xtalks Spotlight
    • Life Science Podcast
    • Xtalks Clinical Edge™
    • Community Features
    • Peer Circles
  • Industry Jobs
    • Search Jobs
    • Post Job
    • Talent Acquisition & Branding Bundle
  • Partner With Us
    • All Services
    • Host a Webinar
    • Spotlight Videos
    • Editorial Features
    • Xtalks Clinical Edge™ Magazine
    • Life Science Podcast
    • Email Marketing
    • Pharmaville
    • Marketing Insights Blog
  • About
    • About Us
    • Frequently Asked Questions
    • Xtalks Team
    • Join The Community
  • Contact

Loren DeVito, PhD

Loren DeVito, PhD is a contributing Xtalks journalist with over 10 years of scientific communications experience. Loren received her bachelor's in psychology at Cornell University and her PhD in neuroscience at Boston University. She was also a Post-doctoral Fellow at the Hospital for Sick Children on a grant supported by the Alzheimer's Society of Canada. Her research included hippocampal and prefrontal contributions to memory and cognition at the behavioral, systems, and cellular levels. She also pursued study of pre-clinical models of schizophrenia and Alzheimer's disease. Loren is committed to communicating evidence-based information to professional and consumer audiences in a digestible and engaging manner, and greatly enjoys science storytelling.

Acquired Blepharoptosis: Levation Pharma Launches Clinical Trial

Acquired blepharoptosis
News March 6, 2023

Jaypirca (pirtobrutinib) Is Now FDA Approved to Treat Relapsed or Refractory Mantle Cell Lymphoma

Jaypirca (pirtobrutinib)
News February 3, 2023

Brukinsa (zanubrutinib) Gets FDA Approval for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Brukinsa (zanubrutinib)
News January 26, 2023

Briumvi is FDA Approved for Relapsing Forms of Multiple Sclerosis

Briumvi (ublituximab-xiiy)
News January 6, 2023

Krazati (adagrasib) Approved for KRASG12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Krazati (adagrasib) approved for NSCLC
News December 15, 2022

Unique ADHD Biomarkers Revealed from MRI Data from the Adolescent Brain Cognitive Development Study

ADHD Biomarkers study
News November 29, 2022

Sotyktu (deucravacitinib) Gets FDA Approval for Moderate-to-Severe Plaque Psoriasis

Sotyktu (deucravacitinib) Gets FDA Approval for Moderate-to-Severe Plaque Psoriasis
News September 16, 2022

Cytimmune Sciences Unveils the Therapeutic Potential of Their Novel Cancer Nanomedicines

Cytimmune Sciences dual cytokine immunotherapy.
News August 29, 2022

Blueprint Medicines Gets Positive Top-Line Data of Ayvakit (avapritinib) for Non-Advanced Systemic Mastocytosis

avapritinib
News August 22, 2022

FDA Expands Stelara (ustekinumab) Indication to Treat Pediatric Patients with Active Psoriatic Arthritis

FDA Expands Stelara (ustekinumab) Indication to Treat Pediatric Patients with Active Psoriatic Arthritis
News August 5, 2022

Baxter Issues a Recall of Their Abacus Drug Compounding Software

The US FDA characterized the Abacus Compounding Software as a Class I recall.
News August 2, 2022

FDA Accepts BLA For Byondis’ Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine

Byondis’ Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine
News July 25, 2022
Next Page »
Sign up for our newsletters and receive webinars, vitals and updates for your topic of choice.
Please review our privacy policy and understand that we may occasionally inform you of similar content if you press submit to subscribe to a newsletter. You may unsubscribe at anytime.

Webinars

  • All Life Sciences
  • Pharma
  • Biotech
  • Medtech
  • Healthcare
  • Research
  • Food

Features

  • All Xtalks Editorial
  • News
  • Blogs
  • Xtalks Spotlight
  • Xtalks Clinical Edge™
  • Search Industry Jobs
  • Post Jobs

Partner

  • All Services
  • Host a Webinar
  • Spotlight Videos
  • Editorial Features
  • Digital Magazine
  • Life Science Podcast
  • Email Marketing

About

  • About Us
  • Contact Us
  • FAQ
  • Meet the Team
  • Privacy Policy
  • Terms of Use
  • Privacy Preferences

My Xtalks

  • Login
  • My Profile
  • Edit Profile
  • Join Xtalks
  • Xtalks Peer Circles
  • Back To Top

Login

Already have an account at Xtalks? Login with:

Facebook Google Linkedin

Or

Lost Password?

Don't have an account?Join

Join

Create an account for access to webinars, jobs, news, blogs, discussions and more. Join thousands of other professionals from life science, medical device and food industries.

Create an account using

Facebook Google Linkedin

Or

Create an Account Using Your Email

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
*

Have an account? Login Here

To create an account, you will need to agree to the privacy policy and terms of use by clicking the agree button at the bottom of this form.

Privacy Policy

This privacy policy describes the privacy practices for www.Xtalks.com (hereafter referred to as “the Site”). Citizens of the UK and EU should refer to EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC. All users of the Site should read this privacy policy in conjunction with the Site’s TERMS OF USE. The Site is owned and operated by Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”). By using the Site, you agree to be bound by the Site’s Terms of Use and accept our Privacy Policy. Please note that our Privacy Policy and Terms of (more…)

Registration Successful

Success! You're almost there. Check your email to access your Xtalks account password and instructions to reset it.

Got your password? Login Here

You must register for this webinar before messaging the presenter!

Register

Copyright 2026 Honeycomb Worldwide Inc. All Rights Reserved. Site by Trew Knowledge.